OU Medicine News



Date: 7-21-2017


For more information, call:
Vallery Brown
OU Medical Center/
The Children’s Hospital at OU Medical Center
(405) 271-7900 X9



OKLAHOMA CITY – OU Medical Center has once again received internationally recognized accreditation for its bone marrow transplant program by the Foundation for the Accreditation of Cellular Therapy (FACT).

OU Medical Center has the only comprehensive allogeneic (using donors) FACT-accredited bone marrow transplant program in Oklahoma and is the only program for both autologous (coming from the patient) and allogeneic bone marrow transplants in the state. The program treats adults and children with leukemia, lymphomas and other bone marrow diseases using blood stem cells from related and unrelated donors as well as umbilical cord blood.

The bone marrow transplant (BMT) program has been continuously accredited since the establishment of accreditation 20 years ago and has risk-adjusted outcomes that position it as one of the top-performing BMT programs nationally. 

“Stem cell transplantation requires a team of multiple specialists, and FACT accreditation spotlights the OU Medicine Blood and Marrow Transplant Program as having wide-ranging competencies that allow us to provide nationally recognized care right here in Oklahoma,” said Dr. George Selby, director of the transplant program and hematologist at Stevenson Cancer Center.  

FACT is an internationally recognized accrediting body for hospitals and medical institutions offering stem cell transplant. The accreditation means OU Medical Center has met the most rigorous standards in every aspect of stem cell therapy. This covers the entire spectrum of stem cell therapy, from clinical care to donor management, cell collection, processing, storage, transportation, administration and cell release.

Accreditation is attained through evaluation of submitted documentation as well as an on-site inspection to determine if an organization is in compliance with current FACT standards and the United States Food and Drug Administration’s current rules for Good Tissue Practice.

FACT standards are defined by leading experts based on the latest knowledge of the field of cellular therapy transplantation. OU Medical Center has been found to be in compliance with these rigorous standards as well as governmental regulations.

“This accreditation underscores our commitment to individuals undergoing cancer treatment and bone marrow transplant in Oklahoma and the region,” said Casey Woods, vice president of operations for OU Medical Center. “The fact that we've been continuously accredited for the past two decades and consistently have among the best patient outcomes in the region further shows that we make it a priority to give our patients the high-quality care they deserve.”

 “We are pleased that OU Medical Center has met the requirements of the foundation and has been granted accreditation for bone marrow transplant,” said Dr. Phyllis Warkentin, FACT’s chief medical officer.

Read more about the program here




OU Medicine is the collective brand for OU Medical Center, OU Physicians and the University of Oklahoma College of Medicine. Headquartered at the Oklahoma Health Center campus near downtown Oklahoma City, OU Medicine is the state’s largest academic medical complex. Among other things, it provides health care, conducts medical research and educates the physicians of tomorrow. 

OU Medical Center is home to the state’s only Level I Trauma Center and The Children’s Hospital at OU Medical Center is Oklahoma’s most comprehensive pediatric facility. Members of OU Physicians, the state’s largest physicians group, provide care at the hospital facilities and at OU Physicians clinics in Oklahoma City and across the state. The practice includes almost every adult and child specialty, and some of its physicians have pioneered treatments or procedures that are world-firsts. Together, we make up OU Medicine and we’re helping keep Oklahoma alive and well. Find us on Facebook, Twitter, Instagram and YouTube and at www.oumedicine.com.



In December 1994, the International Society for Cellular Therapy (ISCT) and the American Society for Blood and Marrow Transplantation (ASBMT) merged their Standards into a single document covering all aspects of hematopoietic cell therapy (collection, processing, and transplantation). The two societies established FACT in order to develop a voluntary Inspection and Accreditation Program based on the joint Standards. FACT promotes quality medical and laboratory practice of cellular therapy through its peer-developed standards and voluntary inspection and accreditation program.

In 2006, FACT, in collaboration with the Joint Accreditation Committee–ISCT & EBMT (JACIE), developed international standards in the field of cellular therapy. JACIE was founded by the European Group for Blood and Marrow Transplantation (EBMT) and the International Society for Cellular Therapy (ISCT), the two leading scientific organizations involved with cellular transplantation in Europe.

Since 2007, FACT accreditation has been used in determining the U.S. News & World report rankings of transplant centers for the "America's Best Hospitals" and "America's Best Children's Hospitals" list.

The FACT Inspection and Accreditation Program was developed by Dr. Phyllis Warkentin, Chief Medical Officer of FACT, the FACT Board of Directors, as well as the ISCT and ASBMT Regulatory and Standards Committees. The first edition of the FACT Standards was published in September 1996, and the first inspections began in September of 1997 resulting in the first program being awarded accreditation in 1998.